{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,18]],"date-time":"2026-04-18T06:52:31Z","timestamp":1776495151345,"version":"3.51.2"},"reference-count":65,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2014,1,3]],"date-time":"2014-01-03T00:00:00Z","timestamp":1388707200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Acta Neuropathol"],"published-print":{"date-parts":[[2014,5]]},"DOI":"10.1007\/s00401-013-1236-0","type":"journal-article","created":{"date-parts":[[2014,1,2]],"date-time":"2014-01-02T14:00:18Z","timestamp":1388671218000},"page":"621-632","source":"Crossref","is-referenced-by-count":65,"title":["CSF Apo-E levels associate with cognitive decline and MRI changes"],"prefix":"10.1007","volume":"127","author":[{"name":"For the Alzheimer\u2019s Disease Neuroimaging Initiative","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jon B.","family":"Toledo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiao","family":"Da","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael W.","family":"Weiner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David A.","family":"Wolk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sharon X.","family":"Xie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steven E.","family":"Arnold","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christos","family":"Davatzikos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leslie M.","family":"Shaw","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John Q.","family":"Trojanowski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,1,3]]},"reference":[{"issue":"4","key":"1236_CR1","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1161\/01.STR.0000064320.73388.C6","volume":"34","author":"K Aoki","year":"2003","unstructured":"Aoki K, Uchihara T, Sanjo N, Nakamura A, Ikeda K, Tsuchiya K, Wakayama Y (2003) Increased expression of neuronal apolipoprotein E in human brain with cerebral infarction. Stroke 34(4):875\u2013880. doi: 10.1161\/01.STR.0000064320.73388.C6","journal-title":"Stroke"},{"issue":"2","key":"1236_CR2","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.ajpath.2011.10.024","volume":"180","author":"GS Baird","year":"2012","unstructured":"Baird GS, Nelson SK, Keeney TR, Stewart A, Williams S, Kraemer S, Peskind ER, Montine TJ (2012) Age-dependent changes in the cerebrospinal fluid proteome by slow off-rate modified aptamer array. Am J Pathol 180(2):446\u2013456. doi: 10.1016\/j.ajpath.2011.10.024","journal-title":"Am J Pathol"},{"issue":"6","key":"1236_CR3","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1006\/nbdi.1999.0251","volume":"6","author":"U Boschert","year":"1999","unstructured":"Boschert U, Merlo-Pich E, Higgins G, Roses AD, Catsicas S (1999) Apolipoprotein E expression by neurons surviving excitotoxic stress. Neurobiol Dis 6(6):508\u2013514. doi: 10.1006\/nbdi 1999.0251","journal-title":"Neurobiol Dis"},{"issue":"4","key":"1236_CR4","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1172\/JCI112130","volume":"76","author":"JK Boyles","year":"1985","unstructured":"Boyles JK, Pitas RE, Wilson E, Mahley RW, Taylor JM (1985) Apolipoprotein E associated with astrocytic glia of the central nervous system and with nonmyelinating glia of the peripheral nervous system. J Clin Invest 76(4):1501\u20131513. doi: 10.1172\/JCI112130","journal-title":"J Clin Invest"},{"issue":"5","key":"1236_CR5","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1212\/01.WNL.0000137041.86153.42","volume":"63","author":"D Bunce","year":"2004","unstructured":"Bunce D, Fratiglioni L, Small BJ, Winblad B, Backman L (2004) APOE and cognitive decline in preclinical Alzheimer disease and non-demented aging. Neurology 63(5):816\u2013821","journal-title":"Neurology"},{"key":"1236_CR6","author":"SC Burnham","year":"2013","unstructured":"Burnham SC, Faux NG, Wilson W, Laws SM, Ames D, Bedo J, Bush AI, Doecke JD, Ellis KA, Head R, Jones G, Kiiveri H, Martins RN, Rembach A, Rowe CC, Salvado O, Macaulay SL, Masters CL, Villemagne VL (2013) A blood-based predictor for neocortical Abeta burden in Alzheimer\u2019s disease: results from the AIBL study. Mol Psychiatry. doi: 10.1038\/mp.2013.40","journal-title":"Mol Psychiatry"},{"issue":"89","key":"1236_CR7","doi-asserted-by":"crossref","first-page":"89ra57","DOI":"10.1126\/scitranslmed.3002156","volume":"3","author":"JM Castellano","year":"2011","unstructured":"Castellano JM, Kim J, Stewart FR, Jiang H, DeMattos RB, Patterson BW, Fagan AM, Morris JC, Mawuenyega KG, Cruchaga C, Goate AM, Bales KR, Paul SM, Bateman RJ, Holtzman DM (2011) Human apoE isoforms differentially regulate brain amyloid-beta peptide clearance. Sci Transl Med 3(89):89ra57. doi: 10.1126\/scitranslmed.3002156","journal-title":"Sci Transl Med"},{"issue":"5123","key":"1236_CR8","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1126\/science.8346443","volume":"261","author":"EH Corder","year":"1993","unstructured":"Corder EH, Saunders AM, Strittmatter WJ, Schmechel DE, Gaskell PC, Small GW, Roses AD, Haines JL, Pericak-Vance MA (1993) Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer\u2019s disease in late onset families. Science 261(5123):921\u2013923","journal-title":"Science"},{"issue":"19 Pt 2","key":"1236_CR9","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.1212\/01.wnl.0000304038.37421.cc","volume":"70","author":"S Cosentino","year":"2008","unstructured":"Cosentino S, Scarmeas N, Helzner E, Glymour MM, Brandt J, Albert M, Blacker D, Stern Y (2008) APOE epsilon 4 allele predicts faster cognitive decline in mild Alzheimer disease. Neurology 70(19 Pt 2):1842\u20131849. doi: 10.1212\/01.wnl.0000304038.37421.cc","journal-title":"Neurology"},{"issue":"6075","key":"1236_CR10","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1126\/science.1217697","volume":"335","author":"PE Cramer","year":"2012","unstructured":"Cramer PE, Cirrito JR, Wesson DW, Lee CY, Karlo JC, Zinn AE, Casali BT, Restivo JL, Goebel WD, James MJ, Brunden KR, Wilson DA, Landreth GE (2012) ApoE-directed therapeutics rapidly clear beta-amyloid and reverse deficits in AD mouse models. Science 335(6075):1503\u20131506. doi: 10.1126\/science.1217697","journal-title":"Science"},{"issue":"20","key":"1236_CR11","doi-asserted-by":"crossref","first-page":"4558","DOI":"10.1093\/hmg\/dds296","volume":"21","author":"C Cruchaga","year":"2012","unstructured":"Cruchaga C, Kauwe JS, Nowotny P, Bales K, Pickering EH, Mayo K, Bertelsen S, Hinrichs A, Fagan AM, Holtzman DM, Morris JC, Goate AM (2012) Cerebrospinal fluid APOE levels: an endophenotype for genetic studies for Alzheimer\u2019s disease. Hum Mol Genet 21(20):4558\u20134571. doi: 10.1093\/hmg\/dds296","journal-title":"Hum Mol Genet"},{"issue":"7","key":"1236_CR12","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1016\/j.neurobiolaging.2009.07.015","volume":"32","author":"T Darreh-Shori","year":"2011","unstructured":"Darreh-Shori T, Modiri N, Blennow K, Baza S, Kamil C, Ahmed H, Andreasen N, Nordberg A (2011) The apolipoprotein E epsilon4 allele plays pathological roles in AD through high protein expression and interaction with butyrylcholinesterase. Neurobiol Aging 32(7):1236\u20131248. doi: 10.1016\/j.neurobiolaging.2009.07.015","journal-title":"Neurobiol Aging"},{"issue":"10","key":"1236_CR13","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1001\/archneurol.2012.1282","volume":"69","author":"JD Doecke","year":"2012","unstructured":"Doecke JD, Laws SM, Faux NG, Wilson W, Burnham SC, Lam CP, Mondal A, Bedo J, Bush AI, Brown B, De Ruyck K, Ellis KA, Fowler C, Gupta VB, Head R, Macaulay SL, Pertile K, Rowe CC, Rembach A, Rodrigues M, Rumble R, Szoeke C, Taddei K, Taddei T, Trounson B, Ames D, Masters CL, Martins RN (2012) Blood-based protein biomarkers for diagnosis of Alzheimer disease. Arch Neurol 69(10):1318\u20131325. doi: 10.1001\/archneurol2012.1282","journal-title":"Arch Neurol"},{"issue":"44","key":"1236_CR14","doi-asserted-by":"crossref","first-page":"34144","DOI":"10.1074\/jbc.M110.108100","volume":"285","author":"JJ Donkin","year":"2010","unstructured":"Donkin JJ, Stukas S, Hirsch-Reinshagen V, Namjoshi D, Wilkinson A, May S, Chan J, Fan J, Collins J, Wellington CL (2010) ATP-binding cassette transporter A1 mediates the beneficial effects of the liver X receptor agonist GW3965 on object recognition memory and amyloid burden in amyloid precursor protein\/presenilin 1 mice. J Biol Chem 285(44):34144\u201334154. doi: 10.1074\/jbc.M110.108100","journal-title":"J Biol Chem"},{"issue":"16","key":"1236_CR15","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1001\/jama.1997.03550160069041","volume":"278","author":"LA Farrer","year":"1997","unstructured":"Farrer LA, Cupples LA, Haines JL, Hyman B, Kukull WA, Mayeux R, Myers RH, Pericak-Vance MA, Risch N, van Duijn CM (1997) Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium. JAMA 278(16):1349\u20131356","journal-title":"JAMA"},{"issue":"4","key":"1236_CR16","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.jalz.2012.01.001","volume":"8","author":"MJ Figurski","year":"2012","unstructured":"Figurski MJ, Waligorska T, Toledo J, Vanderstichele H, Korecka M, Lee VM, Trojanowski JQ, Shaw LM (2012) Improved protocol for measurement of plasma beta-amyloid in longitudinal evaluation of Alzheimer\u2019s disease neuroimaging initiative study patients. Alzheimers Dement 8(4):250\u2013260. doi: 10.1016\/j.jalz.2012.01.001","journal-title":"Alzheimers Dement"},{"issue":"6135","key":"1236_CR17","doi-asserted-by":"crossref","first-page":"924-c","DOI":"10.1126\/science.1235809","volume":"340","author":"NF Fitz","year":"2013","unstructured":"Fitz NF, Cronican AA, Lefterov I, Koldamova R (2013) Comment on \u201cApoE-directed therapeutics rapidly clear beta-amyloid and reverse deficits in AD mouse models\u201d. Science 340(6135):924-c. doi: 10.1126\/science.1235809","journal-title":"Science"},{"issue":"Pt 7","key":"1236_CR18","doi-asserted-by":"crossref","first-page":"2201","DOI":"10.1093\/brain\/awt127","volume":"136","author":"JK Foster","year":"2013","unstructured":"Foster JK, Albrecht MA, Savage G, Lautenschlager NT, Ellis KA, Maruff P, Szoeke C, Taddei K, Martins R, Masters CL, Ames D (2013) Lack of reliable evidence for a distinctive {varepsilon}4-related cognitive phenotype that is independent from clinical diagnostic status: findings from the Australian imaging, biomarkers and lifestyle study. Brain 136(Pt 7):2201\u20132216. doi: 10.1093\/brain\/awt127","journal-title":"Brain"},{"issue":"3","key":"1236_CR19","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1159\/000008157","volume":"43","author":"R Fukuyama","year":"2000","unstructured":"Fukuyama R, Mizuno T, Mori S, Yanagisawa K, Nakajima K, Fushiki S (2000) Age-dependent decline in the apolipoprotein E level in cerebrospinal fluid from control subjects and its increase in cerebrospinal fluid from patients with Alzheimer\u2019s disease. Eur Neurol 43(3):161\u2013169 (8157)","journal-title":"Eur Neurol"},{"issue":"3","key":"1236_CR20","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1172\/JCI112645","volume":"78","author":"RE Gregg","year":"1986","unstructured":"Gregg RE, Zech LA, Schaefer EJ, Stark D, Wilson D, Brewer HB Jr (1986) Abnormal in vivo metabolism of apolipoprotein E4 in humans. J Clin Invest 78(3):815\u2013821. doi: 10.1172\/JCI112645","journal-title":"J Clin Invest"},{"issue":"12","key":"1236_CR21","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1212\/WNL.0b013e318211c352","volume":"76","author":"VB Gupta","year":"2011","unstructured":"Gupta VB, Laws SM, Villemagne VL, Ames D, Bush AI, Ellis KA, Lui JK, Masters C, Rowe CC, Szoeke C, Taddei K, Martins RN (2011) Plasma apolipoprotein E and Alzheimer disease risk: the AIBL study of aging. Neurology 76(12):1091\u20131098. doi: 10.1212\/WNL.0b013e318211c352","journal-title":"Neurology"},{"issue":"1","key":"1236_CR22","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1136\/jnnp.2008.150433","volume":"80","author":"MD Haag","year":"2009","unstructured":"Haag MD, Hofman A, Koudstaal PJ, Stricker BH, Breteler MM (2009) Statins are associated with a reduced risk of Alzheimer disease regardless of lipophilicity. The Rotterdam study. J Neurol Neurosurg Psychiatry 80(1):13\u201317. doi: 10.1136\/jnnp.2008.150433","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"Pt 3","key":"1236_CR23","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1093\/brain\/awq008","volume":"133","author":"Z Hong","year":"2010","unstructured":"Hong Z, Shi M, Chung KA, Quinn JF, Peskind ER, Galasko D, Jankovic J, Zabetian CP, Leverenz JB, Baird G, Montine TJ, Hancock AM, Hwang H, Pan C, Bradner J, Kang UJ, Jensen PH, Zhang J (2010) DJ-1 and alpha-synuclein in human cerebrospinal fluid as biomarkers of Parkinson\u2019s disease. Brain 133(Pt 3):713\u2013726. doi: 10.1093\/brain\/awq008","journal-title":"Brain"},{"issue":"9","key":"1236_CR24","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1212\/WNL.0b013e318266fa70","volume":"79","author":"WT Hu","year":"2012","unstructured":"Hu WT, Holtzman DM, Fagan AM, Shaw LM, Perrin R, Arnold SE, Grossman M, Xiong C, Craig-Schapiro R, Clark CM, Pickering E, Kuhn M, Chen Y, Van Deerlin VM, McCluskey L, Elman L, Karlawish J, Chen-Plotkin A, Hurtig HI, Siderowf A, Swenson F, Lee VM, Morris JC, Trojanowski JQ, Soares H (2012) Plasma multianalyte profiling in mild cognitive impairment and Alzheimer disease. Neurology 79(9):897\u2013905. doi: 10.1212\/WNL.0b013e318266fa70","journal-title":"Neurology"},{"issue":"6","key":"1236_CR25","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.molmed.2010.04.004","volume":"16","author":"Y Huang","year":"2010","unstructured":"Huang Y (2010) Abeta-independent roles of apolipoprotein E4 in the pathogenesis of Alzheimer\u2019s disease. Trends Mol Med 16(6):287\u2013294. doi: 10.1016\/j.molmed.2010.04.004","journal-title":"Trends Mol Med"},{"issue":"15","key":"1236_CR26","doi-asserted-by":"crossref","first-page":"8838","DOI":"10.1073\/pnas.151254698","volume":"98","author":"Y Huang","year":"2001","unstructured":"Huang Y, Liu XQ, Wyss-Coray T, Brecht WJ, Sanan DA, Mahley RW (2001) Apolipoprotein E fragments present in Alzheimer\u2019s disease brains induce neurofibrillary tangle-like intracellular inclusions in neurons. Proc Natl Acad Sci USA 98(15):8838\u20138843. doi: 10.1073\/pnas.151254698","journal-title":"Proc Natl Acad Sci USA"},{"issue":"4","key":"1236_CR27","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1002\/jmri.21049","volume":"27","author":"CR Jack Jr","year":"2008","unstructured":"Jack CR Jr, Bernstein MA, Fox NC, Thompson P, Alexander G, Harvey D, Borowski B, Britson PJ, Whitwell JL, Ward C, Dale AM, Felmlee JP, Gunter JL, Hill DL, Killiany R, Schuff N, Fox-Bosetti S, Lin C, Studholme C, DeCarli CS, Krueger G, Ward HA, Metzger GJ, Scott KT, Mallozzi R, Blezek D, Levy J, Debbins JP, Fleisher AS, Albert M, Green R, Bartzokis G, Glover G, Mugler J, Weiner MW (2008) The Alzheimer\u2019s disease neuroimaging initiative (ADNI): MRI methods. J Magn Reson Imaging 27(4):685\u2013691. doi: 10.1002\/jmri.21049","journal-title":"J Magn Reson Imaging"},{"issue":"5","key":"1236_CR28","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/j.neuron.2008.04.010","volume":"58","author":"Q Jiang","year":"2008","unstructured":"Jiang Q, Lee CY, Mandrekar S, Wilkinson B, Cramer P, Zelcer N, Mann K, Lamb B, Willson TM, Collins JL, Richardson JC, Smith JD, Comery TA, Riddell D, Holtzman DM, Tontonoz P, Landreth GE (2008) ApoE promotes the proteolytic degradation of Abeta. Neuron 58(5):681\u2013693. doi: 10.1016\/j.neuron.2008.04.010","journal-title":"Neuron"},{"issue":"7","key":"1236_CR29","doi-asserted-by":"crossref","first-page":"e70269","DOI":"10.1371\/journal.pone.0070269","volume":"8","author":"S Kim","year":"2013","unstructured":"Kim S, Swaminathan S, Inlow M, Risacher SL, Nho K, Shen L, Foroud TM, Petersen RC, Aisen PS, Soares H, Toledo JB, Shaw LM, Trojanowski JQ, Weiner MW, McDonald BC, Farlow MR, Ghetti B, Saykin AJ (2013) Influence of genetic variation on plasma protein levels in older adults using a multi-analyte panel. PLoS One 8(7):e70269. doi: 10.1371\/journal.pone.0070269","journal-title":"PLoS One"},{"key":"1236_CR30","doi-asserted-by":"crossref","unstructured":"Korff A, Liu C, Ginghina C, Shi M, Zhang J (2013) \u03b1-Synuclein in cerebrospinal fluid of Alzheimer\u2019s disease and mild cognitive impairment. J Alzheimers Dis 36(4):679\u2013688. doi: 10.3233\/JAD-130458","DOI":"10.3233\/JAD-130458"},{"key":"1236_CR31","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/1750-1326-8-18","volume":"8","author":"KD LaClair","year":"2013","unstructured":"LaClair KD, Manaye KF, Lee DL, Allard JS, Savonenko AV, Troncoso JC, Wong PC (2013) Treatment with bexarotene, a compound that increases apolipoprotein-E, provides no cognitive benefit in mutant APP\/PS1 mice. Mol Neurodegener 8:18. doi: 10.1186\/1750-1326-8-18","journal-title":"Mol Neurodegener"},{"issue":"6135","key":"1236_CR32","doi-asserted-by":"crossref","first-page":"924-g","DOI":"10.1126\/science.1234114","volume":"340","author":"GE Landreth","year":"2013","unstructured":"Landreth GE, Cramer PE, Lakner MM, Cirrito JR, Wesson DW, Brunden KR, Wilson DA (2013) Response to comments on \u201cApoE-directed therapeutics rapidly clear beta-amyloid and reverse deficits in AD mouse models\u201d. Science 340(6135):924-g. doi: 10.1126\/science.1234114","journal-title":"Science"},{"issue":"1","key":"1236_CR33","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/BF00225071","volume":"95","author":"T Lehtimaki","year":"1995","unstructured":"Lehtimaki T, Pirttila T, Mehta PD, Wisniewski HM, Frey H, Nikkari T (1995) Apolipoprotein E (apoE) polymorphism and its influence on ApoE concentrations in the cerebrospinal fluid in Finnish patients with Alzheimer\u2019s disease. Hum Genet 95(1):39\u201342","journal-title":"Hum Genet"},{"issue":"2","key":"1236_CR34","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1038\/nrneurol.2012.263","volume":"9","author":"CC Liu","year":"2013","unstructured":"Liu CC, Kanekiyo T, Xu H, Bu G (2013) Apolipoprotein E and Alzheimer disease: risk, mechanisms and therapy. Nat Rev Neurol 9(2):106\u2013118. doi: 10.1038\/nrneurol.2012.263","journal-title":"Nat Rev Neurol"},{"issue":"9","key":"1236_CR35","doi-asserted-by":"crossref","first-page":"R903","DOI":"10.1152\/ajpregu.00219.2012","volume":"303","author":"M Liu","year":"2012","unstructured":"Liu M, Kuhel DG, Shen L, Hui DY, Woods SC (2012) Apolipoprotein E does not cross the blood-cerebrospinal fluid barrier, as revealed by an improved technique for sampling CSF from mice. Am J Physiol Regul Integr Comp Physiol 303(9):R903\u2013R908. doi: 10.1152\/ajpregu.00219.2012","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"issue":"2","key":"1236_CR36","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/0169-328X(91)90111-A","volume":"11","author":"J Poirier","year":"1991","unstructured":"Poirier J, Hess M, May PC, Finch CE (1991) Astrocytic apolipoprotein E mRNA and GFAP mRNA in hippocampus after entorhinal cortex lesioning. Brain Res Mol Brain Res 11(2):97\u2013106","journal-title":"Brain Res Mol Brain Res"},{"issue":"6135","key":"1236_CR37","doi-asserted-by":"crossref","first-page":"924-d","DOI":"10.1126\/science.1234089","volume":"340","author":"AR Price","year":"2013","unstructured":"Price AR, Xu G, Siemienski ZB, Smithson LA, Borchelt DR, Golde TE, Felsenstein KM (2013) Comment on \u201cApoE-directed therapeutics rapidly clear beta-amyloid and reverse deficits in AD mouse models\u201d. Science 340(6135):924-d. doi: 10.1126\/science.1234089","journal-title":"Science"},{"issue":"16","key":"1236_CR38","doi-asserted-by":"crossref","first-page":"6820","DOI":"10.1073\/pnas.0900345106","volume":"106","author":"EM Reiman","year":"2009","unstructured":"Reiman EM, Chen K, Liu X, Bandy D, Yu M, Lee W, Ayutyanont N, Keppler J, Reeder SA, Langbaum JB, Alexander GE, Klunk WE, Mathis CA, Price JC, Aizenstein HJ, DeKosky ST, Caselli RJ (2009) Fibrillar amyloid-beta burden in cognitively normal people at 3 levels of genetic risk for Alzheimer\u2019s disease. Proc Natl Acad Sci USA 106(16):6820\u20136825. doi: 10.1073\/pnas.0900345106","journal-title":"Proc Natl Acad Sci USA"},{"issue":"4","key":"1236_CR39","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1016\/j.neuroimage.2010.07.020","volume":"53","author":"M Reuter","year":"2010","unstructured":"Reuter M, Rosas HD, Fischl B (2010) Highly accurate inverse consistent registration: a robust approach. Neuroimage 53(4):1181\u20131196. doi: 10.1016\/j.neuroimage.2010.07.020","journal-title":"Neuroimage"},{"issue":"4","key":"1236_CR40","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1016\/j.neuroimage.2012.02.084","volume":"61","author":"M Reuter","year":"2012","unstructured":"Reuter M, Schmansky NJ, Rosas HD, Fischl B (2012) Within-subject template estimation for unbiased longitudinal image analysis. Neuroimage 61(4):1402\u20131418. doi: 10.1016\/j.neuroimage.2012.02.084","journal-title":"Neuroimage"},{"issue":"45","key":"1236_CR41","doi-asserted-by":"crossref","first-page":"11445","DOI":"10.1523\/JNEUROSCI.1972-08.2008","volume":"28","author":"DR Riddell","year":"2008","unstructured":"Riddell DR, Zhou H, Atchison K, Warwick HK, Atkinson PJ, Jefferson J, Xu L, Aschmies S, Kirksey Y, Hu Y, Wagner E, Parratt A, Xu J, Li Z, Zaleska MM, Jacobsen JS, Pangalos MN, Reinhart PH (2008) Impact of apolipoprotein E (ApoE) polymorphism on brain ApoE levels. J Neurosci 28(45):11445\u201311453. doi: 10.1523\/JNEUROSCI.1972-08.2008","journal-title":"J Neurosci"},{"issue":"9","key":"1236_CR42","doi-asserted-by":"crossref","first-page":"4646","DOI":"10.1073\/pnas.76.9.4646","volume":"76","author":"PS Roheim","year":"1979","unstructured":"Roheim PS, Carey M, Forte T, Vega GL (1979) Apolipoproteins in human cerebrospinal fluid. Proc Natl Acad Sci USA 76(9):4646\u20134649","journal-title":"Proc Natl Acad Sci USA"},{"issue":"4","key":"1236_CR43","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1002\/ana.21610","volume":"65","author":"LM Shaw","year":"2009","unstructured":"Shaw LM, Vanderstichele H, Knapik-Czajka M, Clark CM, Aisen PS, Petersen RC, Blennow K, Soares H, Simon A, Lewczuk P, Dean R, Siemers E, Potter W, Lee VM, Trojanowski JQ (2009) Cerebrospinal fluid biomarker signature in Alzheimer\u2019s disease neuroimaging initiative subjects. Ann Neurol 65(4):403\u2013413. doi: 10.1002\/ana.21610","journal-title":"Ann Neurol"},{"issue":"5","key":"1236_CR44","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1007\/s00401-011-0808-0","volume":"121","author":"LM Shaw","year":"2011","unstructured":"Shaw LM, Vanderstichele H, Knapik-Czajka M, Figurski M, Coart E, Blennow K, Soares H, Simon AJ, Lewczuk P, Dean RA, Siemers E, Potter W, Lee VM, Trojanowski JQ (2011) Qualification of the analytical and clinical performance of CSF biomarker analyses in ADNI. Acta Neuropathol 121(5):597\u2013609. doi: 10.1007\/s00401-011-0808-0","journal-title":"Acta Neuropathol"},{"issue":"10","key":"1236_CR45","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1001\/archneurol.2011.203","volume":"68","author":"NE Shepardson","year":"2011","unstructured":"Shepardson NE, Shankar GM, Selkoe DJ (2011) Cholesterol level and statin use in Alzheimer disease: I. Review of epidemiological and preclinical studies. Arch Neurol 68(10):1239\u20131244. doi: 10.1001\/archneurol.2011.203","journal-title":"Arch Neurol"},{"issue":"11","key":"1236_CR46","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1001\/archneurol.2011.242","volume":"68","author":"NE Shepardson","year":"2011","unstructured":"Shepardson NE, Shankar GM, Selkoe DJ (2011) Cholesterol level and statin use in Alzheimer disease: II. Review of human trials and recommendations. Arch Neurol 68(11):1385\u20131392. doi: 10.1001\/archneurol.2011.242","journal-title":"Arch Neurol"},{"issue":"10","key":"1236_CR47","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1001\/archneurol.2012.1070","volume":"69","author":"HD Soares","year":"2012","unstructured":"Soares HD, Potter WZ, Pickering E, Kuhn M, Immermann FW, Shera DM, Ferm M, Dean RA, Simon AJ, Swenson F, Siuciak JA, Kaplow J, Thambisetty M, Zagouras P, Koroshetz WJ, Wan HI, Trojanowski JQ, Shaw LM (2012) Plasma biomarkers associated with the apolipoprotein E genotype and Alzheimer disease. Arch Neurol 69(10):1310\u20131317. doi: 10.1001\/archneurol2012.1070","journal-title":"Arch Neurol"},{"issue":"6135","key":"1236_CR48","doi-asserted-by":"crossref","first-page":"924-e","DOI":"10.1126\/science.1233937","volume":"340","author":"I Tesseur","year":"2013","unstructured":"Tesseur I, Lo AC, Roberfroid A, Dietvorst S, Van Broeck B, Borgers M, Gijsen H, Moechars D, Mercken M, Kemp J, D\u2019Hooge R, De Strooper B (2013) Comment on \u201cApoE-directed therapeutics rapidly clear beta-amyloid and reverse deficits in AD mouse models\u201d. Science 340(6135):924-e. doi: 10.1126\/science.1233937","journal-title":"Science"},{"issue":"Pt 9","key":"1236_CR49","doi-asserted-by":"crossref","first-page":"2697","DOI":"10.1093\/brain\/awt188","volume":"136","author":"JB Toledo","year":"2013","unstructured":"Toledo JB, Arnold SE, Raible K, Brettschneider J, Xie SX, Grossman M, Monsell SE, Kukull WA, Trojanowski JQ (2013) Contribution of cerebrovascular disease in autopsy confirmed neurodegenerative disease cases in the National Alzheimer\u2019s Coordinating Centre. Brain 136(Pt 9):2697\u20132706. doi: 10.1093\/brain\/awt188","journal-title":"Brain"},{"issue":"5","key":"1236_CR50","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1007\/s00401-013-1148-z","volume":"126","author":"JB Toledo","year":"2013","unstructured":"Toledo JB, Korff A, Shaw LM, Trojanowski JQ, Zhang J (2013) CSF alpha-synuclein improves diagnostic and prognostic performance of CSF tau and Abeta in Alzheimer\u2019s disease. Acta Neuropathol 126(5):683\u2013697. doi: 10.1007\/s00401-013-1148-z","journal-title":"Acta Neuropathol"},{"issue":"2","key":"1236_CR51","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/alzrt162","volume":"5","author":"JB Toledo","year":"2013","unstructured":"Toledo JB, Shaw LM, Trojanowski JQ (2013) Plasma amyloid beta measurements\u2014a desired but elusive Alzheimer\u2019s disease biomarker. Alzheimers Res Ther 5(2):8. doi: 10.1186\/alzrt162","journal-title":"Alzheimers Res Ther"},{"issue":"4","key":"1236_CR52","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1007\/s00401-011-0861-8","volume":"122","author":"JB Toledo","year":"2011","unstructured":"Toledo JB, Vanderstichele H, Figurski M, Aisen PS, Petersen RC, Weiner MW, Jack CR Jr, Jagust W, Decarli C, Toga AW, Toledo E, Xie SX, Lee VM, Trojanowski JQ, Shaw LM (2011) Factors affecting Abeta plasma levels and their utility as biomarkers in ADNI. Acta Neuropathol 122(4):401\u2013413. doi: 10.1007\/s00401-011-0861-8","journal-title":"Acta Neuropathol"},{"issue":"5","key":"1236_CR53","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1007\/s00401-013-1151-4","volume":"126","author":"JB Toledo","year":"2013","unstructured":"Toledo JB, Xie SX, Trojanowski JQ, Shaw LM (2013) Longitudinal change in CSF Tau and Abeta biomarkers for up to 48\u00a0months in ADNI. Acta Neuropathol 126(5):659\u2013670. doi: 10.1007\/s00401-013-1151-4","journal-title":"Acta Neuropathol"},{"issue":"7","key":"1236_CR54","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1016\/j.neurobiolaging.2009.07.005","volume":"32","author":"T Vanmierlo","year":"2011","unstructured":"Vanmierlo T, Rutten K, Dederen J, Bloks VW, van Vark-van der Zee LC, Kuipers F, Kiliaan A, Blokland A, Sijbrands EJ, Steinbusch H, Prickaerts J, Lutjohann D, Mulder M (2011) Liver X receptor activation restores memory in aged AD mice without reducing amyloid. Neurobiol Aging 32(7):1262\u20131272. doi: 10.1016\/j.neurobiolaging.2009.07.005","journal-title":"Neurobiol Aging"},{"issue":"6135","key":"1236_CR55","doi-asserted-by":"crossref","first-page":"924-f","DOI":"10.1126\/science.1235505","volume":"340","author":"K Veeraraghavalu","year":"2013","unstructured":"Veeraraghavalu K, Zhang C, Miller S, Hefendehl JK, Rajapaksha TW, Ulrich J, Jucker M, Holtzman DM, Tanzi RE, Vassar R, Sisodia SS (2013) Comment on \u201cApoE-directed therapeutics rapidly clear beta-amyloid and reverse deficits in AD mouse models\u201d. Science 340(6135):924-f. doi: 10.1126\/science.1235505","journal-title":"Science"},{"key":"1236_CR56","author":"S Vijayaraghavan","year":"2013","unstructured":"Vijayaraghavan S, Maetzler W, Reimold M, Lithner CU, Liepelt-Scarfone I, Berg D, Darreh-Shori T (2013) High apolipoprotein E in cerebrospinal fluid of patients with Lewy body disorders is associated with dementia. Alzheimers Dement. doi: 10.1016\/j.jalz.2013.03.010","journal-title":"Alzheimers Dement"},{"issue":"4","key":"1236_CR57","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/S1474-4422(13)70044-9","volume":"12","author":"VL Villemagne","year":"2013","unstructured":"Villemagne VL, Burnham S, Bourgeat P, Brown B, Ellis KA, Salvado O, Szoeke C, Macaulay SL, Martins R, Maruff P, Ames D, Rowe CC, Masters CL (2013) Amyloid beta deposition, neurodegeneration, and cognitive decline in sporadic Alzheimer\u2019s disease: a prospective cohort study. Lancet Neurol 12(4):357\u2013367. doi: 10.1016\/S1474-4422(13)70044-9","journal-title":"Lancet Neurol"},{"key":"1236_CR58","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1750-1326-2-7","volume":"2","author":"SE Wahrle","year":"2007","unstructured":"Wahrle SE, Shah AR, Fagan AM, Smemo S, Kauwe JS, Grupe A, Hinrichs A, Mayo K, Jiang H, Thal LJ, Goate AM, Holtzman DM (2007) Apolipoprotein E levels in cerebrospinal fluid and the effects of ABCA1 polymorphisms. Mol Neurodegener 2:7. doi: 10.1186\/1750-1326-2-7","journal-title":"Mol Neurodegener"},{"issue":"1 Suppl","key":"1236_CR59","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.jalz.2011.09.172","volume":"8","author":"MW Weiner","year":"2012","unstructured":"Weiner MW, Veitch DP, Aisen PS, Beckett LA, Cairns NJ, Green RC, Harvey D, Jack CR, Jagust W, Liu E, Morris JC, Petersen RC, Saykin AJ, Schmidt ME, Shaw L, Siuciak JA, Soares H, Toga AW, Trojanowski JQ (2012) The Alzheimer\u2019s disease neuroimaging initiative: a review of papers published since its inception. Alzheimers Dement 8(1 Suppl):S1\u2013S68. doi: 10.1016\/j.jalz.2011.09.172","journal-title":"Alzheimers Dement"},{"issue":"18","key":"1236_CR60","doi-asserted-by":"crossref","first-page":"12029","DOI":"10.1016\/S0021-9258(18)99060-5","volume":"266","author":"KH Weisgraber","year":"1991","unstructured":"Weisgraber KH, Shinto LH (1991) Identification of the disulfide-linked homodimer of apolipoprotein E3 in plasma. Impact on receptor binding activity. J Biol Chem 266(18):12029\u201312034","journal-title":"J Biol Chem"},{"issue":"6","key":"1236_CR61","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1136\/jnnp.72.6.794","volume":"72","author":"M Winnock","year":"2002","unstructured":"Winnock M, Letenneur L, Jacqmin-Gadda H, Dallongeville J, Amouyel P, Dartigues JF (2002) Longitudinal analysis of the effect of apolipoprotein E epsilon4 and education on cognitive performance in elderly subjects: the PAQUID study. J Neurol Neurosurg Psychiatry 72(6):794\u2013797","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"22","key":"1236_CR62","doi-asserted-by":"crossref","first-page":"10256","DOI":"10.1073\/pnas.1001412107","volume":"107","author":"DA Wolk","year":"2010","unstructured":"Wolk DA, Dickerson BC (2010) Apolipoprotein E (APOE) genotype has dissociable effects on memory and attentional-executive network function in Alzheimer\u2019s disease. Proc Natl Acad Sci USA 107(22):10256\u201310261. doi: 10.1073\/pnas.1001412107","journal-title":"Proc Natl Acad Sci USA"},{"issue":"19","key":"1236_CR63","doi-asserted-by":"crossref","first-page":"4985","DOI":"10.1523\/JNEUROSCI.5476-05.2006","volume":"26","author":"Q Xu","year":"2006","unstructured":"Xu Q, Bernardo A, Walker D, Kanegawa T, Mahley RW, Huang Y (2006) Profile and regulation of apolipoprotein E (ApoE) expression in the CNS in mice with targeting of green fluorescent protein gene to the ApoE locus. J Neurosci 26(19):4985\u20134994. doi: 10.1523\/JNEUROSCI.5476-05.2006","journal-title":"J Neurosci"},{"issue":"9","key":"1236_CR64","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1001\/archneur.1997.00550210044011","volume":"54","author":"K Yaffe","year":"1997","unstructured":"Yaffe K, Cauley J, Sands L, Browner W (1997) Apolipoprotein E phenotype and cognitive decline in a prospective study of elderly community women. Arch Neurol 54(9):1110\u20131114","journal-title":"Arch Neurol"},{"key":"1236_CR65","author":"L Yu","year":"2013","unstructured":"Yu L, Boyle PA, Leurgans S, Schneider JA, Bennett DA (2013) Disentangling the effects of age and APOE on neuropathology and late life cognitive decline. Neurobiol Aging. doi: 10.1016\/j.neurobiolaging.2013.10.074","journal-title":"Neurobiol Aging"}],"container-title":["Acta Neuropathologica"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00401-013-1236-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00401-013-1236-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00401-013-1236-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,21]],"date-time":"2022-03-21T04:49:20Z","timestamp":1647838160000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00401-013-1236-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,1,3]]},"references-count":65,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2014,5]]}},"alternative-id":["1236"],"URL":"https:\/\/doi.org\/10.1007\/s00401-013-1236-0","relation":{},"ISSN":["0001-6322","1432-0533"],"issn-type":[{"value":"0001-6322","type":"print"},{"value":"1432-0533","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,1,3]]}}}